scholarly journals The taxane-based chemotherapy triplet is superior to the doublet in one to nine node-positive but not node-negative triple-negative breast cancer: results from a retrospective analysis

2020 ◽  
Vol 11 (22) ◽  
pp. 6653-6662
Author(s):  
Sanxing Guo ◽  
Yonggang Shi ◽  
Shuo Lu ◽  
Yujie He ◽  
Guangyi Jin ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Retrospective Analysis ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Node Negative ◽  
Node Positive

Triple negative breast cancer: 5-year results of combined treatment

2014 ◽  
Vol 20 (4) ◽  
pp. 191-198
Author(s):  
Valerijus Ostapenko ◽  
Teresė Pipirienė Želvienė ◽  
Giedrė Smailytė ◽  
Andrej Ostapenko ◽  
Raimundas Meškauskas
Keyword(s):  
Breast Cancer ◽  
Retrospective Analysis ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Therapeutic Option ◽  
Combined Treatment ◽  
Disease Free Survival ◽  
Rank Test ◽  
Biological Behaviour ◽  
Metastatic Setting

Background. Breast cancer is the most common female cancer worldwide. It is a heterogeneous disease with regard to biological behaviour, responses to treatment and prognosis. The term “triple negative breast cancer” (TNBC), namely, refers to the immunohistochemical classification of breast tumours lacking ER, PgR, and HER2 protein expression. TNBC does not respond to endocrine therapy and chemotherapy remains the main systemic therapeutic option in the adjuvant and metastatic setting of TNBC. The aim of this study was a retrospective analysis of the results of combined treatment for TNBC. Patient and methods. In our retrospective analysis, we analized 431 patients with TNBC treated with combination therapy from March 2005 until December 2009 at the Institute of Oncology, Vilnius University. 52.20% of the whole group of patients were women older than 50 years. Stage I was diagnosed in 23.9%, stage II in 49.65%, stage III in 22.74%, stage IV in 3.71% of cases. According to pathological types of the tumour ductal invasive carcinoma was diagnosed in 376 patients (87.24%) and tumour grade G3 was determined in 330 patients (76.57%). All 431 patients underwent surgical treatment, 239 patients had chemotherapy (55.45%). The disease-free survival and overall survival were estimated by the Kaplan-Meier method. The Log-rank test was used for survival comparison between the groups. P 

Triple-negative breast cancer: A single-institution retrospective analysis.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e11543-e11543
Author(s):  
P. K. Julka ◽  
S. Mallick ◽  
S. Pandit ◽  
N. P. Joshi ◽  
A. Gandhi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Retrospective Analysis ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Single Institution

Metronomic maintenance therapy (MMT) and prevention of relapses in patients with triple-negative breast cancer (TNBC)? A retrospective analysis.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e12037-e12037
Author(s):  
Shripad Dinanath Banavali ◽  
Abhay Yashwant Desai ◽  
Ajit Madhukar Kulkarni ◽  
Vivek Sukadev Nirabhawane ◽  
Netaji Rangrao Patil ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Maintenance Therapy ◽  
Retrospective Analysis ◽  
Triple Negative Breast Cancer ◽  
Triple Negative

Metaplastic progression free survival compared to triple negative breast cancer, a retrospective analysis.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e12552-e12552
Author(s):  
Maryam B. Lustberg ◽  
Amanda Luff ◽  
Gregory S. Young ◽  
Rachel M. Layman ◽  
Ewa Mrozek ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Retrospective Analysis ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Progression Free Survival ◽  
Free Survival
Sign in / Sign up

Export Citation Format

Share Document